Original Articles


CellR4 2024; 12: e3438
DOI: 10.32113/cellr4_20249_3438

Exploring the impact of strength training methods on blood pressure and heart rate variability: a comparative analysis of traditional, superset, and tri-set approaches

CellR4 2023; 11: e3419
DOI: 10.32113/cellr4_202312_3419

Investigation of the effects of B16F10 derived exosomes in induction of immunosuppressive phenotype in the hematopoietic stem cells

CellR4 2022; 10: e3332
DOI: 10.32113/cellr4_202210_3332

Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study

CellR4 2022; 10: e3322
DOI: 10.32113/cellr4_20228_3322

The cellular markers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune response

CellR4 2022; 10: e3289
DOI: 10.32113/cellr4_20223_3289

Decreased Treg/Th17 ratio in Bulgarian patients after liver transplantation: a single-center experience

CellR4 2021; 9: e3280
DOI: 10.32113/cellr4_202112_3280

Intravenous SONG-modulated laser-activated allogeneic cord blood mesenchymal stem cells for the treatment of end-stage heart failure: a preliminary clinical study

CellR4 2021; 9: e3251
DOI: 10.32113/cellr4_20219_3251

High SOX2 expression as an indicator of the potential involvement of cancer stem cells in the development of cervical cancer among females with HPV infection

CellR4 2021; 9: e3130
DOI: 10.32113/cellr4_20214_3130

Autologous Bone Marrow Aspirate Stem Cell Concentrate (BMAC) for treatment of patients with Fontaine stages III-IV peripheral arterial disease: a pilot safety and feasibility study

CellR4 2021; 9: e3132
DOI: 10.32113/cellr4_20214_3132

Safety and efficacy of systemically administered autologous Gold-Induced Cytokines (GOLDIC®)

CellR4 2021; 9: e3060
DOI: 10.32113/cellr4_20212_3060

Adipose-derived Stromal Vascular Matrix (SVM): a new paradigm in regenerative medicine

CellR4 2019; 7: e2613
DOI: 10.32113/cellr4_20194_2613

Encapsulated and ‘free’ pig islet xenotransplantation: recent experience and clinical progress*

CellR4 2019; 7: e2611
DOI: 10.32113/cellr4_20194_2611

Adipose derived Stromal Vascular Fraction (SVF) cells in the treatment of rheumatoid arthritis of the hand: a 2-year follow-up study

CellR4 2018; 6 (3): e2533

Adipose-derived stromal vascular fraction (SVF) cells in the treatment of rheumatoid arthritis of the hand

CellR4 2018; 6 (2): e2519

Automated isolation and expansion of human adipose tissue-derived stem cells for a seamless translation into clinical trials